Victor F. Mautner

3.9k total citations
68 papers, 2.4k citations indexed

About

Victor F. Mautner is a scholar working on Neurology, Epidemiology and Rheumatology. According to data from OpenAlex, Victor F. Mautner has authored 68 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Neurology, 33 papers in Epidemiology and 17 papers in Rheumatology. Recurrent topics in Victor F. Mautner's work include Neurofibromatosis and Schwannoma Cases (66 papers), Meningioma and schwannoma management (33 papers) and Neuroblastoma Research and Treatments (16 papers). Victor F. Mautner is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (66 papers), Meningioma and schwannoma management (33 papers) and Neuroblastoma Research and Treatments (16 papers). Victor F. Mautner collaborates with scholars based in Germany, United States and Canada. Victor F. Mautner's co-authors include Lan Kluwe, Reinhard E. Friedrich, Jan M. Friedman, Christian Hagel, Scott R. Plotkin, Thorsten Derlin, C. Fünsterer, Miriam A. Bredella, Armin Kurtz and Gordon J. Harris and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Neurology.

In The Last Decade

Victor F. Mautner

65 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victor F. Mautner Germany 27 2.0k 891 678 556 347 68 2.4k
Victor‐Felix Mautner Germany 29 2.1k 1.1× 925 1.0× 723 1.1× 526 0.9× 355 1.0× 116 2.8k
Eva Dombi United States 35 2.5k 1.3× 1.1k 1.2× 498 0.7× 975 1.8× 455 1.3× 98 3.3k
Hideaki NUKUI Japan 27 1.3k 0.7× 429 0.5× 294 0.4× 389 0.7× 195 0.6× 143 2.3k
Liwei Zhang China 24 775 0.4× 513 0.6× 378 0.6× 320 0.6× 117 0.3× 123 2.1k
Chang Jin Kim South Korea 23 727 0.4× 657 0.7× 355 0.5× 576 1.0× 107 0.3× 99 1.9k
Carmelo Lucio Sturiale Italy 25 1.2k 0.6× 562 0.6× 212 0.3× 362 0.7× 225 0.6× 173 2.4k
Francesco Maiuri Italy 28 1.3k 0.7× 1.1k 1.3× 273 0.4× 491 0.9× 170 0.5× 126 2.4k
Masahiro Shin Japan 30 2.1k 1.0× 1.3k 1.5× 232 0.3× 347 0.6× 133 0.4× 170 3.3k
Nakamasa Hayashi Japan 27 923 0.5× 425 0.5× 349 0.5× 663 1.2× 116 0.3× 180 2.8k
Marc Polivka France 29 558 0.3× 458 0.5× 268 0.4× 385 0.7× 215 0.6× 77 2.1k

Countries citing papers authored by Victor F. Mautner

Since Specialization
Citations

This map shows the geographic impact of Victor F. Mautner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor F. Mautner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor F. Mautner more than expected).

Fields of papers citing papers by Victor F. Mautner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor F. Mautner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor F. Mautner. The network helps show where Victor F. Mautner may publish in the future.

Co-authorship network of co-authors of Victor F. Mautner

This figure shows the co-authorship network connecting the top 25 collaborators of Victor F. Mautner. A scholar is included among the top collaborators of Victor F. Mautner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor F. Mautner. Victor F. Mautner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaul, Michael G., Antonia Zapf, Christoph Riedel, et al.. (2024). Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI. Neuro-Oncology Advances. 6(1). vdae021–vdae021. 4 indexed citations
2.
3.
Madesta, Frederic, Lennart Well, Isabel Molwitz, et al.. (2022). Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Neuro-Oncology. 24(10). 1790–1798. 14 indexed citations
4.
Berry, Philip, et al.. (2018). Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. BMC Research Notes. 11(1). 520–520. 4 indexed citations
5.
Hagel, Christian, et al.. (2017). The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells. American Journal Of Pathology. 187(7). 1623–1632. 17 indexed citations
6.
Farschtschi, Said, et al.. (2016). Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2. Muscle & Nerve. 55(3). 350–358. 16 indexed citations
7.
Jett, Kimberly, Rosa Nguyen, Patricia Birch, et al.. (2015). Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1. American Journal of Medical Genetics Part A. 167(7). 1518–1524. 5 indexed citations
8.
Salamon, Johannes, László Papp, Zoltán Tóth, et al.. (2015). Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT. PLoS ONE. 10(12). e0143305–e0143305. 19 indexed citations
9.
Merker, Vanessa L., Miriam A. Bredella, Wenli Cai, et al.. (2014). Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis. American Journal of Medical Genetics Part A. 164(6). 1431–1437. 44 indexed citations
10.
Schnabel, Claudia, Stefan Dahm, Thomas Streichert, et al.. (2014). Differences of 25-hydroxyvitamin D3 concentrations in children and adults with neurofibromatosis type 1. Clinical Biochemistry. 47(7-8). 560–563. 14 indexed citations
11.
Scherwath, Angela, et al.. (2013). Psychische Belastung von Erwachsenen mit Neurofibromatose Typ 1: Eine Längsschnittstudie. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. 63(2). 85–92. 4 indexed citations
12.
Smith, Miriam J., Sonia Esparza, Vanessa L. Merker, et al.. (2012). Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis. Clinical Biochemistry. 46(7-8). 698–700. 3 indexed citations
13.
Blessmann, Marco, Alexander Gröbe, Alexander Quaas, et al.. (2011). Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1–associated tumors. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 113(2). 239–244. 5 indexed citations
14.
Kluwe, Lan, Christian Hagel, Rosa Nguyen, et al.. (2011). Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors. PLoS ONE. 6(6). e21099–e21099. 40 indexed citations
15.
Jaremko, Jacob L., Peter MacMahon, Martin Torriani, et al.. (2011). Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis. Skeletal Radiology. 41(8). 917–923. 22 indexed citations
16.
Hummel, Trent R., Walter J. Jessen, Shyra J. Miller, et al.. (2010). Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin. Clinical Cancer Research. 16(20). 5048–5057. 37 indexed citations
17.
Buchert, Ralph, Florian Wilke, Reinhard E. Friedrich, et al.. (2008). Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1. Nuclear Medicine Communications. 29(1). 17–26. 12 indexed citations
18.
Hagel, Christian, Matthias Peiper, Lan Kluwe, et al.. (2006). Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors. Journal of Neuro-Oncology. 82(2). 187–192. 57 indexed citations
19.
Friedrich, Reinhard E., et al.. (1998). Tumorreduktion plexiformer Neurofibrome im kraniofazialen und Halsbereich. Mund- Kiefer- und Gesichtschirurgie. 2(S1). S86–S90. 3 indexed citations
20.
Merel, P., Khê Hoang‐Xuan, Marc Sanson, et al.. (1995). Screening for germ‐line mutations in the NF2 Gene. Genes Chromosomes and Cancer. 12(2). 117–127. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor‐Felix Mautner Breakdown of academic impact, for papers by Eva Dombi Breakdown of academic impact, for papers by Hideaki NUKUI Breakdown of academic impact, for papers by Liwei Zhang Breakdown of academic impact, for papers by Chang Jin Kim Breakdown of academic impact, for papers by Carmelo Lucio Sturiale Breakdown of academic impact, for papers by Francesco Maiuri Breakdown of academic impact, for papers by Masahiro Shin Breakdown of academic impact, for papers by Nakamasa Hayashi Breakdown of academic impact, for papers by Marc Polivka
Rankless by CCL
2026